000 01612 a2200433 4500
005 20250514204559.0
264 0 _c20041119
008 200411s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jc.2004-0446
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZeender, E
245 0 0 _aPioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cOct 2004
300 _a5059-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aGlucose
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aInsulin
_xmetabolism
650 0 4 _aInsulin Secretion
650 0 4 _aInterleukin-1
_xmetabolism
650 0 4 _aIslets of Langerhans
_xcytology
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aPioglitazone
650 0 4 _aSodium Salicylate
_xpharmacology
650 0 4 _aThiazolidinediones
_xpharmacology
700 1 _aMaedler, K
700 1 _aBosco, D
700 1 _aBerney, T
700 1 _aDonath, M Y
700 1 _aHalban, P A
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 89
_gno. 10
_gp. 5059-66
856 4 0 _uhttps://doi.org/10.1210/jc.2004-0446
_zAvailable from publisher's website
999 _c15163733
_d15163733